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Rosalind Norkett,1 Alison E. Twelvetrees,1 Lewis D. Griffin,2 and Josef T. Kittler1
The astrocytic GLT-1 (or EAAT2) is the major glutamate transporter for clearing synaptic glutamate. While the diffusion
dynamics of neurotransmitter receptors at the neuronal surface are well understood, far less is known regarding the surface
trafficking of transporters in subcellular domains of the astrocyte membrane. Here, we have used live-cell imaging to study
the mechanisms regulating GLT-1 surface diffusion in astrocytes in dissociated and brain slice cultures. Using GFP-time lapse
imaging, we show that GLT-1 forms stable clusters that are dispersed rapidly and reversibly upon glutamate treatment in a
transporter activity-dependent manner. Fluorescence recovery after photobleaching and single particle tracking using quan-
tum dots revealed that clustered GLT-1 is more stable than diffuse GLT-1 and that glutamate increases GLT-1 surface diffu-
sion in the astrocyte membrane. Interestingly, the two main GLT-1 isoforms expressed in the brain, GLT-1a and GLT-1b, are
both found to be stabilized opposed to synapses under basal conditions, with GLT-1b more so. GLT-1 surface mobility is
increased in proximity to activated synapses and alterations of neuronal activity can bidirectionally modulate the dynamics of
both GLT-1 isoforms. Altogether, these data reveal that astrocytic GLT-1 surface mobility, via its transport activity, is modu-
lated during neuronal firing, which may be a key process for shaping glutamate clearance and glutamatergic synaptic
transmission.
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Introduction
Glutamate is the major excitatory neurotransmitter in themammalian central nervous system affecting neuronal
and glial function by acting on glutamate receptors. Main-
taining the correct level of extracellular glutamate is crucial
for neuronal transmission and network activity. Glutamate
clearance is achieved by diffusion away from the synaptic cleft
in conjunction with glutamate uptake by excitatory amino
acid transporters (EAATs). These plasma membrane transport-
ers use energy from the transmembrane ionic gradients to
remove glutamate from the extracellular space (Attwell et al.,
1993; Danbolt, 2001; Kanner and Schuldiner, 1987;
Tzingounis and Wadiche, 2007). This glutamate uptake
function allows EAATs to terminate and shape excitatory syn-
aptic transmission, and prevent neuronal excitotoxicity
(Rosenberg et al., 1992; Tzingounis and Wadiche, 2007).
EAAT2/GLT-1 is highly expressed in the hippocampus
and cortex and is the main astrocytic transporter involved in
extracellular glutamate clearance in the adult forebrain
(Chaudhry et al., 1995; Holmseth et al., 2012; Kojima et al.,
1999; Ullensvang et al., 1997). Global knockout of GLT-1
results in toxic increases in extracellular glutamate concentra-
tions within the CNS, inducing lethal spontaneous seizures
(Rothstein et al., 1996; Tanaka et al., 1997). Regulation of
GLT-1 expression, activity and trafficking modulates gluta-
mate uptake and is implicated in plasticity (Omrani et al.,
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2009) and pathology (Danbolt, 2001; Petr et al., 2015; Tzin-
gounis and Wadiche, 2007) making it a key target for new
therapeutics (Soni et al., 2014). Two main isoforms of GLT-1
are expressed in astrocytes in the adult brain, GLT-1a and
GLT-1b (Chen et al., 2002, 2004; Holmseth et al., 2009;
Sullivan et al., 2004), which differ only in their C-terminal
tails. Unlike GLT-1a, the GLT-1b isoform contains a PDZ
binding domain that plays a role in its trafficking via interac-
tion with PDZ domain containing scaffold proteins such as
DLG1, PSD95, and PICK1 (Bassan et al., 2008; Gonzalez-
Gonzalez et al., 2008a; Underhill et al., 2015).
The molecular mechanisms that regulate GLT-1 expres-
sion, trafficking, exocytosis and endocytosis are increasingly
well understood (Gonzalez-Gonzalez et al., 2008b; Kalan-
dadze et al., 2002; Peacey et al., 2009; Rothstein et al., 2005;
Shih et al., 2014; Susarla and Robinson, 2008; Underhill
et al., 2015). In contrast, while it is now well established that
the activity-dependent regulation of neurotransmitter receptor
surface diffusion dynamics in the neuronal membrane is a
key mechanism for regulating synaptic signalling (Choquet
and Triller, 2013; Groc et al., 2004; Levi et al., 2008; Muir
et al., 2010), far less is known regarding the regulatory mech-
anisms of transporter surface diffusion in subdomains of the
astrocyte membrane. Recently, it was shown that GLT-1 sur-
face diffusion can be increased by glutamate and that impair-
ing GLT-1 surface mobility impacted the kinetics of neuronal
excitatory postsynaptic currents (Murphy-Royal et al., 2015).
However, whether GLT-1 isoforms exhibit differential surface
diffusion on the astrocyte membrane, and the consequences
of neuronal activity alterations and neuronal firing on GLT-1
surface clustering and mobility at individual activated synap-
ses remain far less clear. Moreover, whether differences exist
in the activity-dependent regulation of GLT-1 surface traffick-
ing in astrocytes in dissociated culture compared to astrocytes
in situ has also not been fully explored.
Here, using live cell imaging and fluorescence recovery
after photobleaching (FRAP), we show that GLT-1 can be
found as clusters on the astrocyte surface that are rapidly dis-
persed upon glutamate treatment, dependent on GLT-1 trans-
porter activity. Interestingly, using single particle tracking, we
find that both GLT-1a and GLT-1b, exhibit a more confined
surface diffusion in regions of astrocyte processes proximal to
synaptic sites, with the GLT-1b isoform more stable in these
regions than GLT-1a. Additionally, we demonstrate that neu-
ronal activity bidirectionally regulates the surface diffusion of
both GLT-1 isoforms providing a mechanism to increase
GLT-1 mobility at individual activated synapses. Finally, by
imaging organotypic brain slices, we also show that GLT-1
undergoes similar activity-dependent regulation in astrocyte
processes in situ in intact tissue. The activity-dependent regu-
lation of GLT-1 surface diffusion may play a key role in




Rat GLT-1a cDNA was N-terminally tagged with EGFP by PCR
cloning in frame into pEGFP-C1 (Clontech) using primers (written
50–30) with the following N and C-terminal GLT-1a sequences,
respectively: ATGGCATCAACCGAGGGTGC and TTATTTTT-
CACGTTTCCAAGGTTCTTCCTC. GLT-1a and GLT-1b are
identical over the first 551 residues, differing only in the C-termini.
Thus, GLT-1b was derived from the GLT-1a cDNA using the same
N-terminal primer, but replacing the C-terminal primer with one
containing the GLT-1b specific sequence (lowercase) as follows: tca-
tatgcaggtctcgatatccaggaatgggaaagg TACCTTGCACTCATCTATTAC
GACAGAG. V5 tags were introduced by PCR into GLT-1a and 1b
between two proline residues (P199 and P200) in the extracellular
loop using the following primers: cctgctgggcctggacagcaccCCATCCGA
GGAGGCCAATAC; gggttggggatgggcttgccAGGTGCCACCAGAACT
TTCT where lowercase text corresponds to the sequence of the V5
tag. GLT-1a-V5 plasmid was a kind gift from Rattray Lab (Peacey
et al., 2009). Presynaptically targeted GCaMP5 (SyGCaMP5) was
cloned using SyGCaMP2 (#26124) (Dreosti et al., 2009) from
Addgene as a target vector and inserting GCaMP5G from Addgene
(#31788) (Akerboom et al., 2012) via the restriction sites SalI and
NotI.
Preparation and Transfection of Astrocyte Cultures
Primary cultures of cortical astrocytes were prepared from E18 or P0
Sprague-Dawley rats as previously described (Banker, 1998). Cells
were maintained in Dulbecco’s modified Eagle’s medium DMEM
GlutaMAX (Invitrogen) supplemented with 4.5 g/L glucose, 20%
fetal bovine serum, 10 u/mL penicillinG, and 100 mg/mL streptomy-
cin at 378C with 5% CO2 in a humidified incubator. Media was
exchanged the day after plating. Astrocytes were passaged when con-
fluency was reached (10 days after plating). Astrocytes were trans-




Preparation and Transfection of Mixed Culture
and the Neuron-Astrocyte Cocultures
Hippocampal cultures were obtained from E18 rat embryos as
described previously with some modifications (Arancibia-Carcamo
et al., 2009). To enrich the culture with astrocytes, the neurons were
kept 24 h after plating in attachment medium (Minimal Essential
Medium, 10% Horse Serum, 1 mM Sodium Pyruvate and 0.6%
Glucose) before replacing with maintenance medium (Neurobasal
Medium, B27 supplement, Glutamax, 0.6% Glucose, Penstrep).
Cells were transfected at 10 days in vitro (DIV10) by lipofectamine
as previously described (Al Awabdh et al., 2012; Smith et al., 2014)
and imaged at DIV13. After transfecting DIV7 hippocampal neu-
rons with SyGCaMP5 (lipofectamine 2000), astrocytes were trans-
fected by nucleofection with 4 mg of GLT-1a-V5 (Amaxa
Nucleofector) and plated on top of the SyGCaMP5 transfected
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neurons (Stephen et al., 2015). Transfected astrocytes were main-
tained with neurons for 3 to 4 days before multi-wavelength live-
imaging.
Organotypic Hippocampal Slice Preparation
and Transfection
Organotypic hippocampal brain slices were prepared following the
Stopini interface method (Stoppini et al., 1991). Transverse brain sli-
ces (300 lm) were obtained from postnatal day 7 (P7) Sprague-
Dawley rats, using a vibratome (Leica VT1200 S) and put in ice-
cold dissection medium [HEPES buffered EBSS (Earle’s Balanced
Salt Solution)]. Slices were cultured on sterile 0.45 lm Omnipore
membrane filters (Millipore) in a humidified incubator at 378C with
5% CO2. Slices were maintained for at least 7 days in culture
medium [72% MEM1 glutamax (GIBCO), 25% HRS, supple-
mented with 20 mM HEPES, 36 mM glucose, and 1.06% Pen-
Strep (10 U mL21, 100 mg ml21) with 16% Nystatin (10,000
U ml21) prior to transfection and imaged 3–6 days later. Media was
changed the day after slicing and every three days after that. Organo-
typic slice cultures were biolistically transfected at 7 DIV using a
Helios gene gun (BioRad; Stephen et al., 2015; Woods and Zito,
2008]. This involved coating small (0.6 mm) gold particles with up
to 25 mg of GFP-GLT-1b-V5. This allowed sparse transfection of
astrocytes in organotypic slices (Benediktsson et al., 2012).
FRAP Imaging and Analysis
Transfected astrocytes were perfused with imaging medium (10 mM
HEPES pH5 7.4, 125 mM NaCl, 10 mM D-Glucose, 5 mM KCl,
2 mM CaCl2, 1 mM MgCl2, and pH5 7.4) at 378C and imaged 2
days later using Zeiss LSM700 confocal with a 633 water objective
(NA: 1.4). Movies were captured using the 488 laser at 1.5%, a
3.53 optical zoom and a 256 3 256 pixel resolution for 250 cycles
(1 second/cycle; Pathania et al., 2014). The pixel dwell time was set
to 3.15 msec and pinhole size was set to 2 mm. Bleaching of the
GFP-GLT-1-V5 with 100% 488-laser intensity occurred after 10
cycles. Clustered and diffuse GFP-GLT-1-V5 in astrocytes processes
were selected for photobleaching. ImageJ was used for measuring the
fluorescence intensity of a manually selected ROI normalized to the
total fluorescence of the image to correct for photobleaching. These
values were normalized to the mean of the 10 frames prior to
bleaching, and the lowest value in the dataset was subtracted from
all values. Finally, the recovery data points were fitted to an expo-
nential recovery curve {y5 a*[12 exp(2b*x)]} using Mathematica
(Wolfram Research) and the average time constant was calculated as
s5 1/b where b is the rate constant. The mobile fraction was calcu-
lated as an average of the plateaued fluorescence level, taken as the
last 20 frames, and presented as a percentage of the prebleached
level.
Single Particle Tracking (SPT)
Fluorescence was captured using an Olympus microscope (BX51WI)
with a 603 water objective (NA: 0.9) Olympus objective coupled to
an EM-CCD camera (Ixon; Andor; Eckel et al., 2015; Muir et al.,
2010; Muir and Kittler, 2014; Smith et al., 2012). Excitation
was provided by a mercury-spiked xenon arc lamp (Cairn) or by a
metal-halide lamp (X-Cite120, EXFO). Appropriate filters were cho-
sen for GFP-tagged constructs, Quantum Dots (QDs), and FM 4-
64. The imaging media used for all experiments contained 125 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM D-glucose,
and 10 mM Hepes and was adjusted to pH5 7.4 with NaOH
before use. Cells were imaged under perfusion (1.5 mL/min) and
heating (35–378C). For recovery experiments, L-Glutamate (100
mM, Sigma) alone or with TFB-TBOA (10 mM, Tocris) were
applied 3 min in the perfusion during imaging. 4-AP (1 mM,
Sigma) and TTX (1 mM, Tocris) were applied 20 min before
imaging.
Labeling of GFP-GLT-1-V5 with QD on dissociated cultures
was performed by first incubating the coverslips with the mouse
anti-V5 antibody (10 mg/mL, Invitrogen) at RT for 6 min, then
incubating for 2 min with an antimouse 605-nm QD (0.5 nM, Invi-
trogen) in imaging media containing 10% horse serum to block
nonspecific binding.
For labeling of GFP-GLT-1-V5 with QD on slice cultures, 2
mL of mouse anti-V5 antibody and 1 mL of anti-mouse 605-nm
QD were mixed in a total volume of 10 mL of imaging medium-
11% BSA and vortexed for 5–10 min at RT and at the lowest
speed. A 35-mm Petri dish was covered with parafilm and a drop
of 150 mL of the anti-V5 QDs-labeled diluted 1 in 1000 in imag-
ing medium1 1% BSA where the slices with the membranes have
been incubated for 10 min at 37C. Slices were washed 3 times in
imaging medium and imaged thereafter. QD movies were recorded
at 8.5 Hz. Labeling of active presynaptic terminals with FM 4-64
(Invitrogen) was performed by a four-step protocol in imaging
media at RT: 10 mM FM 4-64 and 50 mM KCl (1 min); 2 mM
FM4-64 (1 min); imaging media only (20 s); imaging media only
(20 s).
Multiwavelength Imaging and Analysis (Optosplit)
An inverted Zeiss Axiovert 200 microscope (633 1.4 NA oil objec-
tive), attached to an Evolve (EMCCD) camera (Photometrics), fitted
with an image splitter (Optosplit II, Cairn Research), allowed simul-
taneous acquisition of images at two separate emission wavelengths.
Videos were recorded at 8.5 Hz using Micro-manager software
(Edelstein et al., 2010). Excitation was achieved through a D470/
403 filter (Chroma) and emission was split using a 565DCXR
dichroic beam-splitter (Chroma), subsequently collecting with
HQ522/40M and HQ607/75M (Cairn Research) filters for SyG-
CaMP5 and Qdot 605, respectively. A Grass S9 stimulator and a
stimulation bath (Warner Instruments) allowed field stimulation (10
Hz for 10 s) of neuron-astrocyte cocultures prepared as described
previously. Movies were aligned using the Cairn Image Splitter plu-
gin in ImageJ. Graphs showing DF/F0 were plotted using
“Mathematica” (Wolfram Research). Regions of Interest were man-
ually drawn and after background subtraction, fluorescence was nor-
malized to the first 10 frames. QD were tracked automatically in
ImageJ by using Mosaic particle tracker 2D/3D plugin (8), only QD
tracks in the neighboring astrocytic processes with their midpoint
within 8 pixels (<2 mm) of a SyGCaMP5 centroid before the field
stimulation were selected and their coordinates were used to estimate
instantaneous diffusion coefficients as described below.
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Image and Statistical Analysis
All experiments were performed on astrocytes from at least three
individual preparations.
For analysis of intensity measurements in clusters, analysis was
performed in ImageJ by the following method: The StackReg macro
was used to correct for minor coverslip drift (Thevenaz et al., 1998)
then regions were drawn that captured cluster positions across the
image stack. Graphs showing cluster index (V/V0) were plotted using
“Mathematica” (Wolfram Research). Regions of Interest were man-
ually drawn. After background subtraction, standard deviation was
normalized to the first 10 frames (50 s) of the movie (Cluster
Index). Images were acquired every 5 s. The standard deviation from
the consecutive frames ending at t5 15 min was used for analysis
and comparison. P values given are from two-tailed t tests. Values
are given as mean SD; error bars represent SEM (standard error of
the mean).
Automated QD detection and trajectory reconstruction was
performed, as previously described (Muir and Kittler, 2014; Pathania
et al., 2014). The mean squared displacement (MSD) versus time (t)
was calculated for each QD track. Instantaneous diffusion coeffi-
cients (D) were then estimated by fitting a line to the first five
points of the MSD curve, using the 2D diffusion law (MSD5 4Dt).
QD track segments were classified as synaptic if their midpoint was
within 0.5mm (2 pixels) of a FM 4-64 centroid. Box plots display
the interquartile range of diffusion scores, with the median score
highlighted. Error bars represent the SEM. Non-Gaussian data sets
were tested by nonparametric Mann-Whitney test. Indications of sig-
nificance correspond to P-values P< 0.05 (*), P< 0.01, (**) and
P< 0.001 (***).
Results
GLT-1 Clustering and Surface Diffusion
in Astrocytes Cultured Alone
As astrocytic GLT-1 is the major astrocytic transporter
involved in glutamate clearance, we first determined the effect
of glutamate application on GLT-1 surface diffusion in the
absence of neuronal signalling. To achieve this, we expressed
GLT-1 with an N-terminal GFP tag (GFP-GLT-1) in primary
astrocyte cultures and investigated GLT-1 surface clustering
and diffusion dynamics on the astrocyte surface using live-cell
imaging of the GFP fluorescence. We found that under basal
conditions, GFP-GLT-1 formed bright fluorescent clusters in
the astrocyte soma and along processes (Fig. 1A–C). Continu-
ous imaging revealed that the intensities and locations of
GFP-GLT-1 clusters were stable for periods of 15 min (Fig.
1A). Interestingly, GLT-1 clusters rapidly and reversibly dis-
persed during acute glutamate application (100 mM, 3 min,
Fig. 1B). The glutamate-induced loss of GFP-GLT-1 cluster-
ing was marked by a 50% decrease in the clustering index
followed by a complete recovery after washout (Fig. 1D,E).
Next, to examine the influence of transporter activity on
GLT-1 clustering, we investigated the effect of a GLT-1
transporter inhibitor on glutamate induced cluster dispersal.
Intriguingly, blocking transporter activity with TFB-TBOA, a
non-transportable competitive inhibitor prevented the gluta-
mate induced GLT-1 cluster dispersal (Fig. 1C–E). We further
explored the surface mobility of clustered GFP-GLT-1 trans-
porters compared to diffuse GFP-GLT-1 using FRAP (Supp.
Info. Fig. S1). Interestingly, the fluorescence recovery of dif-
fuse GLT-1 was higher in comparison to clustered GLT-1
transporters, suggesting that GLT-1 clustering increases GLT-
1 stability (Fig. 1F). This difference in GLT-1 mobility was
confirmed by a total mobile fraction of GFP-GLT-1 of 52%
in clustered GFP-GLT-1 compared with 77% for the diffuse
GFP-GLT-1 (P5 0.002, Fig. 1G). Furthermore, glutamate
treatment (100 mM, 3 min) increased GLT-1 fluorescence
recovery and the mobile fraction of the diffuse GLT-1 to
100% compared to control, before treatment (P5 0.008, Fig.
1G). Thus, clustered GLT-1 transporters are less mobile than
diffuse GLT-1 transporters, and GLT-1 cluster dispersal upon
glutamate treatment correlates with increased GLT-1 mobility.
Next, we investigated the lateral mobility of GLT-1 molecules
on the astrocyte surface in response to glutamate treatment
by using SPT with QDs. For SPT experiments we used a ver-
sion of GFP-GLT-1 with a V5 extracellular tag inserted in
the large GLT-1 extracellular loop (Supp. Info. Fig. S2A). By
QD tracking we found that GFP-GLT-1-V5 lateral mobility
was significantly increased in response to glutamate (100 mM,
3 min), which was reversed upon glutamate washout
(Fig. 1H). Moreover, the GLT-1 single trajectories explored a
greater area upon glutamate treatment, correlating with
increased GLT-1 lateral diffusion (Fig. 1H). Interestingly,
despite the formation of stable GLT-1 clusters, we found a
linear MSDt plot, reflecting free diffusion (Brownian motion)
of GLT-1 molecules rather than a confined behavior (Fig. 1I)
suggesting a large proportion of GLT-1 is found outside
clusters.
Together, these data reveal that in cultured astrocytes
GLT-1 can form stable clusters, while individual GLT-1 mole-
cules can be highly mobile on the astrocyte surface. Gluta-
mate application leads to GLT-1 cluster dispersal that is
dependent on GLT-1 transporter activity, which correlates
with an increase in GLT-1 surface diffusion in the astrocyte
membrane.
GLT-1 Is More Stable and More Confined inside
Synaptic Areas under Basal Conditions
Given the glutamate induced alteration in GLT-1 surface dif-
fusion, next we wanted to determine whether the presence of
neurons and synaptic contacts could affect astrocytic GLT-1
surface dynamics. Interestingly, we observed that in the pres-
ence of neurons there was a 2 fold increase in GLT-1 surface
diffusion in astrocyte-neuron cocultures in comparison to
GLT-1 in astrocytes cultured alone (Supp. Info. Fig. S2B),
Al Awabdh et al.: Dynamic Regulation of GLT-1 Surface Diffusion
July 2016 1255
FIGURE 1: Regulation of GLT-1 surface diffusion by glutamate is transporter activity dependent. Astrocytes cultured alone and trans-
fected with GFP-GLT-1 or GFP-GLT-1-V5 and imaged live after 4 to 7 days expression. A–C: Representative time lapse imaging illustrates
the GFP-GLT-1 clusters in control untreated astrocytes (A), treated with 100 lM Glu (B) or with 10 lM TFB-TBOA1100 lM Glu (C). Con-
trol images before treatment of a whole astrocyte (left panel). Schematic of recovery experiments. Regions boxed in left panels shown
before treatment at 0 min, during treatment at 4min and after recovery at 15 min. Scale bars, 10 lm. D: Time course of GFP-GLT-1 de-
clustering (cluster index, V/V0) in astrocytes control untreated (black, n57 cells), Glu treated (green, n58 cells) and Glu1TFB-TBOA
treated (red, n57 cells) astrocytes. E: Cluster index at 0, 4, and 15 min. Loss of fluorescence in GFP-GLT-1 clusters at 4 min is significant
compared with untreated control (P50.023) but is not significantly different at 15 min (P>0.05). F: Fluorescence Recovery after Photo-
bleaching. Quantification of GFP fluorescence intensity shows the recovery of diffuse GLT-1 (red) is greater than clustered GLT-1 (black)
and that glutamate increases GLT-1 recovery (blue). Data points represent an average of movies and are fitted with single exponentials
(black, red, and blue lines). G: The mobile fraction, quantified as the final amount of recovered fluorescence presented as a percentage
of the total bleached fluorescence, for diffuse GLT-1 (black, n512 videos, 74.6764.890) is significantly increased compared with that
for GLT-1 in clusters (red, n59 videos, 51.9265.120; P50.002, t test) and GLT-1 in glutamate is significantly increased compared with
before treatment (blue, n56 videos, 100.268.769; P50.01, t test). H: Instantaneous diffusion coefficients and (I) MSD versus time,
MSDt plot, and representative single trajectories, Scale bar, 0.5 lm of QD-tagged GFP-GLT-1-V5. Control before treatment (black,
median50.039 lm2/s; n5579 trajectories), after 2 min with 100 lM glutamate (red, median50.044 lm2/s; n5504 trajectories) and
after drug washout (blue, median50.038 lm2/s; n5276 trajectories). Median D is significantly increased upon 100 lM glutamate treat-
ment (P50.005, Mann-Whitney test) but is not significantly different after glutamate washout (P>0.05).
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revealed by more mobile transporters on the astrocyte surface
in presence of neurons (Supp. Info. Fig. S2C and S2D) as
also recently reported by Murphy-Royal. GLT-1a and GLT-1b
are the two main isoforms of GLT-1 expressed in forebrain
and differ only in their intracellular C-terminal sequence
(Fig. 2A). Unlike GLT-1a, GLT-1b has a PDZ binding
domain that interacts with scaffolding proteins (Bassan et al.,
2008; Gonzalez-Gonzalez et al., 2008a; Underhill et al.,
2015). Hence, we next wanted to determine whether astro-
cytic GLT-1a and GLT-1b transporters exhibited differential
surface diffusion properties, depending on their proximity to
active synapses. We expressed GFP-GLT-1a-V5 (Fig. 2B) or
GFP-GLT-1b-V5 (Fig. 2C) in hippocampal astrocyte-neuron
coculture. SPT using QDs along with simultaneous labeling
of the active presynaptic terminals using FM4-64 (Supp. Info.
Fig. S3A), allowed us to track the GLT-1 transporters in
regions of the astrocyte plasma membrane located in close
proximity to synapses (hence forth termed perisynaptic loca-
tions) or in astrocyte regions that were not in proximity to
synapses (termed extrasynaptic locations) (Fig. 2B and Supp.
Info. Fig. S2C).
Interestingly, the median lateral diffusion of perisynaptic
GLT-1a, Dperi was 0.052 mm2/s, whereas the extrasynaptic
GLT-1a, Dext was 0.065 mm2/s, and for GLT-1b, Dperi was
0.047 mm2/s, whereas the extrasynaptic GLT-1b, Dext was
0.071 mm2/s (Fig. 2D,E). This reveals that astrocytic surface
FIGURE 2: GLT-1 is stable and confined inside synaptic areas under basal conditions. Astrocytes in hippocampal neuron-astrocyte mixed
culture transfected with GFP-GLT-1a-V5 or GFP-GLT-1b-V5 at DIV10 and imaged at DIV13 after FM4-64 staining. A: Schematic represen-
tation of GFP-GLT-1(a/b)-V5 labelled by an anti-V5 antibody/QD complex. B,C: Representative time lapse imaging illustrates GFP-GLT-
1a-V5 (B) and GFP-GLT-1b-V5 (C) in a region of an astrocyte. GFP-GLT-1-V5 overlaid with FM4-64 stained synapses (left panels), or by
QD-tagged GFP-GLT-1-V5 trajectories shown in orange (middle panels), and FM4-64 stained synapses overlaid by QD-tagged GFP-GLT-
1-V5 trajectories shown in orange (right panels), Scale bars 5 lm. D: Instantaneous diffusion coefficients of extrasynaptic GLT-1a (red,
median50.065 lm2/s; n5599 trajectories) and perisynaptic GLT-1a (blue, median50.052 lm2/s; n5112 trajectories), median D is sig-
nificantly decreased in perisynaptic areas (P5 6x10 2 3, Mann-Whitney test). E: Instantaneous diffusion coefficients of extrasynaptic GLT-
1b (red, median50.071 lm2/s; n5255 trajectories) and perisynaptic GLT-1b (blue, median50.047 lm2/s; n562 trajectories). Median D
is significantly decreased in perisynaptic areas (P58 3 1025, Mann-Whitney test). MSDt plot of extrasynaptic (F) and perisynaptic (G)
GLT-1a and GLT-1b.
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diffusion of extrasynaptic GLT-1 is more dynamic than peri-
synaptic GLT-1 for both isoforms. No significant difference
was observed between GLT-1a and GLT-1b median lateral
diffusion. Interestingly, MSDt plot of GLT-1a and GLT-1b
revealed differential properties depending on their localisation
relative to the synapse (Fig. 2F,G). The MSDt plot of extrasy-
naptic GLT-1a and GLT-1b exhibited linear profiles, indicat-
ing Brownian diffusion, however, perisynaptic GLT-1a and
GLT-1b exhibited sublinear curvature, indicative of confined
motion. In addition, the differences in transporter mobility
were due to a shift of the diffusive fraction without a signifi-
cant change of the immobile fraction (data not shown). Fur-
thermore, comparison of the extrasynaptic GLT-1a and GLT-
1b MSDt plots revealed no significant difference (Fig. 2F).
However, comparison of the perisynaptic GLT-1a and GLT-
1b MSDt plots revealed that GLT-1b was significantly more
confined compared to GLT-1a (Fig. 2G) and the residency
time of GLT-1b within the perisynaptic area is significantly
longer than GLT-1a (Supp. Info. Fig. S3B).
Together, these data showed that for both isoforms,
perisynaptic GLT-1 is more stable than GLT-1 in extrasynap-
tic regions under basal conditions. Moreover, perisynaptic
GLT-1b is more stable than perisynaptic GLT-1a suggesting a
role of GLT-1b PDZ interactors in its confinement.
Glutamate and Neuronal Activity Regulate the
Surface Diffusion of GLT-1 in Astrocytes
Next, we were interested in further studying the effect of neuro-
nal activity on GLT-1 surface dynamics in astrocytes. As GLT-
1a and GLT-1b showed similar behavior in response to the
pharmacological treatments; here, we have shown the results of
GLT-1a isoform only. For the following experiments, we
expressed GFP-GLT-1a-V5 in hippocampal astrocyte-neuron
coculture and performed single-particle tracking experiments.
Similarly to experiments in astrocytes cultured alone
(Fig. 1H,I), we noticed a rapid and reversible loss of clustered
GFP-GLT-1a-V5 fluorescence (Supp. Info. Fig. S4A) and an
increase in GLT-1a surface diffusion upon glutamate treatment,
which are prevented when the transport activity of astrocytic glu-
tamate transporters is inhibited with TFB-TBOA (Supp. Info.
Fig. S4B and S4C). Since glutamate is released during neuronal
firing, we studied the effect of increased neuronal activity on the
GLT-1a surface dynamics via 4-AP (a nonselective voltage-
dependent K1-channel blocker) treatment in astrocyte-neuron
cocultures (Fig. 3). Similar to glutamate treatment, we observed
a loss of clustered GFP-GLT-1a-V5 fluorescence upon 4-AP
(1 mM, 20 min), which is prevented in the presence of the trans-
porter inhibitor (Fig. 3A1–3). We found significantly increased
GLT-1a (71%, Fig. 3B) surface diffusion following 4-AP
treatment, characterized by more mobile transporters (Fig. 3C).
Furthermore, inhibition of GLT-1 transporter activity with
TFB-TBOA blocked the 4-AP dependent increase in GLT-1a lat-
eral diffusion (Fig. 3B), reverting it to control levels. The MSDt
plot exhibited an upward linear shift, indicative of Brownian
motion and increased lateral diffusion upon 4-AP treatment
(Fig. 3C). These data suggest that stimulating neuronal activity
triggers an increase in GLT-1 surface mobility probably due to
the increased glutamate release upon 4-AP treatment (Girault
et al., 1986).
In contrast, inhibiting neuronal firing with TTX (a
highly selective sodium channel blocker) treatment, led to an
increase in clustered GFP-GLT-1a-V5 (Fig. 3A4) and signifi-
cantly decreased GLT-1a surface diffusion (35%, Fig. 3B),
correlating with less mobile transporters (Fig. 3C). The
MSDt plot exhibited a downward linear shift, indicative of
decreased Brownian motion, but not confinement upon TTX
treatment (Fig. 3C). This result confirmed that inhibition of
neuronal activity decreased GLT-1 surface diffusion (Murphy-
Royal et al., 2015). Glutamate and neuronal activity can also
regulate the surface diffusion dynamics of GLT-1b (Supp.
Info. Figs. S5 and S6). Since the majority of the GLT-1 tra-
jectories in the mixed cultures were from the extrasynaptic
GLT-1 population (87 and 80% of the total GLT-1a and
GLT-1b trajectories, respectively), we propose that pharmaco-
logical alterations in neuronal activity can influence surface
diffusion of the extrasynaptic GLT-1 transporters. Together,
these data showed that neuronal activity bidirectionally regu-
lates GLT-1a and GLT-1b surface mobility on the surface of
astrocytes in a GLT-1 transporter activity-dependent manner.
Next, to determine the effect of neuronal activity on GLT-
1 surface diffusion in astrocytic processes in apposition to synap-
ses undergoing activation, we performed a more physiological
form of neuronal stimulation (electrical field stimulation) of hip-
pocampal neurons transfected with synaptically targeted
GCaMP5 (SyGCaMP5) to label stimulated synapses and co-
cultured with astrocytes pre-transfected with GLT-1-V5 (Fig.
4A). By using an image splitter, we were able to simultaneously
image the neuronal SyGCaMP5 signal and QD-labelled GLT-1
on the astrocyte surface (Fig. 4B). Upon field stimulation (10 Hz
for 10 s, 100 APs), a 2-fold increase was observed in SyGCaMP5
signal, showing that field stimulation drives increased presynaptic
calcium signal and revealing an increase in synaptic activity and
position of activated synapses (Fig. 4C). Interestingly, we
observed that field stimulation increased GLT-1 surface diffusion
in apposition to activated synapses by 100% compared with
before stimulation (Fig. 4D). The activity-dependent increase in
GLT-1 surface diffusion is likely due to the glutamate released in
the synaptic sites during the stimulation.
Glutamate and Neuronal Activity Regulate GLT-1
Surface Diffusion in Ex-Vivo Brain Slices
Very little is known about GLT-1 dynamics in more
physiological and spatially complex tissue, like brain slices.
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To address this, we used hippocampal organotypic brain slices
transfected with GFP-GLT-1-V5 (Fig. 5A). In transfected astro-
cytes, GLT-1 was expressed on the surface of the astrocytes and
formed obvious clusters (Fig. 5A), corroborating previous data
(Benediktsson et al., 2012). After incubating the slices with anti-
V5-QD complexes, we were able to observe QD labeling through-
out the slice, specific only to the transfected astrocytes (Fig. 5B1–
4). First, we found a significant decrease in GLT-1 surface diffu-
sion in brain slices (slice) compared with in dissociated (diss) cul-
tures (Fig. 5C, Dslice was 0.021 mm2/s and Ddiss was 0.067 mm2/
s) where the transporters explored a greater area (Fig. 5D). More-
over, despite a similar explored area by GLT-1 in soma compared
to processes (Fig. 5E) that could be due to more compactly packed
cells and extracellular matrix, we found that GLT-1 coefficient dif-
fusion was significantly lower in processes (proc) compared to
soma (Fig. 5E, Dproc was at 0.021 mm2/s and Dsoma was 0.027
mm2/s). This reduction could be due to the presence on astrocytic
processes of more synaptic sites, where we have previously shown
that GLT-1 is more confined (Fig. 2G). This data suggests that
GLT-1 is more stable in astrocytic processes in apposition to syn-
apses in slice cultures under basal conditions. We then investigated
the effects of glutamate (100 mM, 2 min) and stimulation of neu-
ronal activity with 4-AP (1 mM, 20 min) on GLT-1 surface
dynamics in astrocytic processes (Fig. 5G). Interestingly, surface
GLT-1 is more dynamic in brain slices when treated with gluta-
mate (Dglu5 0.033 mm2/s) or 4-AP (D4-AP 5 0.032 mm2/s), in
comparison to untreated slice control (Dcontrol 5 0.021 mm2/s).
Moreover, the GLT-1 single trajectories explored a greater area
upon glutamate and 4-AP treatment, correlating with increased
GLT-1 lateral diffusion (Fig. 5H). In addition to validating our
results obtained from dissociated cultures that showed neuronal
activity mediated regulation of GLT-1 surface dynamics, these
data are evidence that GLT-1 modulates its surface diffusion upon
stimulation of neuronal activity in brain slices.
Discussion
GLT-1 glutamate transporters are critical modulators of
extracellular glutamate in the brain (Danbolt, 2001;
FIGURE 3: Neuronal activity mediated GLT-1 surface diffusion increase is transporter activity dependent. Hippocampal neuron-
astrocytes mixed culture transfected with GFP-GLT-1a-V5 at DIV10 and imaged at DIV13. A: Representative time lapse imaging illus-
trates GFP-GLT-1a-V5 in a region of interest of an astrocytic process (top panel) and overlaid by QD-tagged GFP-GLT-1a-V5 trajectories
shown in orange (bottom panels) in control untreated (1), treated 20 min with 1 mM 4-AP (2), 20 min with TFB-TBOA 10 lM14-AP
1mM (3) or 1 mM of TTX (4), Scales bars 10 lm. Instantaneous diffusion coefficients (B) and MSDt plot and single trajectories (C) of QD-
tagged GFP-GLT-1-V5. Control untreated (black, median50.08 lm2/s; n51061 trajectories), after 20 min with 1 mM 4-AP (red,
median50.12 lm2/s; n5779 trajectories), after 20 min of TFB-TBOA 10 lM14-AP 1 mM (blue, median50.08 lm2/s; n5282 trajec-
tories) and after 20 min with 1 mM of TTX (green, median50.05 lm2/s; n51191 trajectories). Median D is significantly increased upon
4-AP (P52 3 10214, Mann-Whitney test) and is significantly decreased upon TTX (P51.2 3 10214, Mann-Whitney test) but is not signifi-
cantly different upon TFB-TBOA 10 lM14-AP 1 mM (P>0.05).
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Tzingounis and Wadiche, 2007) and regulating their surface
diffusion and clustering properties to modulate transporter
number at synaptic release sites could be a rapid mechanism
for locally tailoring glutamate uptake to shape glutamatergic
neurotransmission. Here, by using GFP-time lapse imaging,
FRAP and single-particle tracking with QD, we report the
behavior of the two main GLT-1 transporter isoforms (GLT-
1a and GLT-1b) in astrocytic surface domains, under both
basal conditions and in response to neuronal activity. GLT-1a
and GLT-1b, were both found to be highly dynamic at non-
synaptic locations and to exhibit a more confined diffusion
when present in astrocyte membranes adjacent to synapses,
with GLT-1b more so. Moreover, exogenous glutamate appli-
cation or alteration of neuronal firing led to altered GLT-1
surface diffusion in a transporter activity dependent manner
and to an increase in GLT-1 mobility in proximity to acti-
vated synapses. Importantly, we could also observe for the
first time neuronal activity-dependent alterations in GLT1
surface mobilities in astrocyte processes in situ in brain slices.
In cultured astrocytes GLT-1 transporters could form sta-
ble clusters that were rapidly and reversibly dispersed upon glu-
tamate treatment. Interestingly, the glutamate-dependent
increase in GLT-1 de-clustering and surface diffusion was
blocked by the nontransportable competitive inhibitor, TFB-
TBOA, suggesting a critical role for the transport activity of
GLT-1 in regulating its surface dynamics. Indeed, application
of aspartate, another glutamate transporter substrate also led to
GLT-1 cluster dispersal (data not shown), reinforcing the idea
that substrate binding to the GLT-1 transporter can directly
affect its surface diffusion. In agreement with this, inhibition of
GLT-1 transport activity with TBOA under basal conditions
decreased steady state GLT-1 surface diffusion in mixed
neuron-glial cultures (Murphy-Royal et al., 2015) presumably
by inhibiting GLT-1 activation by endogenous glutamate in the
cultures. GLT-1 is mainly found in oligomeric form on the
astrocyte surface (Haugeto et al., 1996), which may facilitate
the formation of the GLT-1 clusters observed in our study,
although FRAP and single-particle tracking resolution do not
allow us to distinguish between the different surface oligomeric
GLT-1 forms. GLT-1 can also interact with scaffolds (Bassan
et al., 2008; Gonzalez-Gonzalez et al., 2008a; Underhill et al.,
2015), which could also contribute to cluster formation.
Substrate-mediated GLT-1 cluster dispersal could be due to the
change in GLT-1 conformation demonstrated in the presence
of its substrates (Qu and Kanner, 2008; Yernool et al., 2004),
which could facilitate oligomer disassembly or uncoupling from
intracellular scaffolds.
Although a recent study reported the surface diffusion
dynamics of the GLT-1a isoform (Murphy-Royal et al, 2015),
the activity-dependent behavior of GLT-1b was not known.
FIGURE 4: Electrical stimulation mediates GLT-1 transporter surface mobility at activated synapses. A: Representative images of hippo-
campal neurons transfected with SyGCaMP5 (green) at 7-10 DIV, cocultured with astrocytes pretransfected with GLT-1-V5 (Red). Cocul-
tures were maintained for 3-4 DIV and imaged using an image splitter. Scale bar, 10 lm. B: Region boxed in (A) and representative
single trajectories shown before stimulation (top panel), and during (bottom panel, 10 Hz for 10 s, 100 PA). Scale bar, 2 lm. C: Time
course of SyGCaMP5 fluorescence F/F0 (6 synapses). Background signal at each corresponding time point was subtracted from the SyG-
CaMP5 signal before normalizing to the first 10 frames (F/F0). D: Percentage of change in GLT-1 surface diffusion significantly increased
during stimulation compared to before (n56 trajectories, P50.04, Mann-Whitney test).
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On studying the two isoforms, we identified two populations
for both GLT-1 isoforms based on their basal surface mobili-
ties in the astrocyte membrane: a perisynaptic population,
characterized by a slower surface diffusion and a more mobile
extrasynaptic population. This is similar to the confinement
of neurotransmitter receptors observed at postsynaptic sites
(Choquet and Triller, 2013), promoting the importance of
specialized astrocytic subdomains proximal to synapses. The
two predominant astrocytic GLT-1 isoforms, GLT-1a and
GLT-1b, differ only in their extreme intracellular C-terminal
sequences. Unlike GLT-1a, GLT-1b, has a PDZ binding
domain that binds to PDZ containing proteins such as
PICK1, PSD95, and DLG1 (Bassan et al., 2008; Gonzalez-
Gonzalez et al., 2008a; Underhill et al., 2015). The confined
motion seen for both perisynaptic GLT-1a and GLT-1b may
be due to protein interacting motifs located in the N-
terminal or C-terminal regions common to both isoforms.
Interestingly, we observed that GLT-1b was more confined in
astrocyte domains close to synapses than GLT-1a under basal
conditions, supporting the concept that the GLT-1b C-termi-
nal PDZ domain interacts with scaffolding proteins, anchor-
ing it to macromolecular glial complexes located in
subcellular domains opposite to neuronal presynaptic sites.
Furthermore, the interaction between the PICK1 scaffolding
protein and GLT-1b has functional consequence on glutamate
transport activity (Sogaard et al., 2013). GLT-1a is known to
form heteromers with GLT-1b (Haugeto et al., 1996; Peacey
et al., 2009) and since GLT-1b interacts with multiple scaf-
folding proteins (Gonzalez-Gonzalez et al., 2009; Underhill
et al., 2015), it could serve to stabilize perisynaptic GLT-1a,
under basal conditions.
We also explored the activity-dependence of GLT-1 syn-
aptic localisation to neuronal activity. MNI-glutamate uncag-
ing experiments on cultured astrocytes provided an initial
suggestion that a glutamate rise could act locally to regulate
GLT-1 surface mobility (Murphy-Royal et al., 2015). How-
ever, in those experiments putative synapses were labeled by
staining for mitochondria which also densely populate
FIGURE 5: Glutamate and neuronal activity regulate GLT-1 surface diffusion in brain slices. A: Example of astrocyte expressing GFP-
GLT-1-V5 and imaged 3–5 days after transfection. Scale bar, 10 lm. B: Zoomed region on an astrocytic process expressing GFP-GLT-1-
V5 (B1), QDs (B2), QDs overlaid with GFP-GLT-1-V5 (B3) and representative QD trajectories (B4). Instantaneous diffusion coefficients
(C,E,G) and MSDt plot of QD-tagged GLT-1 (D,F,H). C,D: In dissociated culture (black, median D50.067 lm2/s; n5783 trajectories) and
in slice cultures (red, median50.021 lm2/s; n5325 trajectories), median D is significantly decreased in slice cultures compared with in
dissociated cultures (P53.5 3 10280, Mann-Whitney test). D,E: In soma (black, median D50.027 lm2/s; n5108 trajectories) and in
processes (red, median D50.021 lm2/s; n5325 trajectories), median D is significantly decreased in processes compared with in soma
(P50.005, Mann-Whitney test). G,H: After 2 min of glutamate 100 lM (red, median D50.033 lm2/s; n5234 trajectories), and after 20
min of 4-AP 1 mM (blue, median D50.032 lm2/s; n5174 trajectories), median D is significantly increased in both treatment conditions
compared with control (Pglu51.15 3 10
210 and P4-AP50.03, Mann-Whitney test).
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dendrites and astrocyte processes themselves (Jackson and
Robinson, 2015; Stephen et al., 2015) and therefore cannot
equivocally label synaptic sites. To directly assess the local
effect of physiologically released glutamate on GLT-1 surface
diffusion, we evoked action potentials to trigger synaptic glu-
tamate release while directly visualizing active synapses using
SyGCaMP5 fluorescence imaging. This, for the first time,
revealed that an increase in GLT-1 surface diffusion in the
neighboring astrocyte processes surrounding the activated syn-
apse. We speculate that during neuronal activity, synaptically
released glutamate is taken up by GLT-1 transporter, resulting
in a change in GLT-1 conformation, which could lead to the
dissociation of GLT-1 from its scaffolding proteins to allow
for increased surface mobility. It will be interesting in the
future to determine the scaffold protein(s) responsible for sta-
bilizing GLT-1 in astrocyte processes close to synapses but it
is tempting to speculate that DLG1 or PICK1 may play a
role.
To extend our findings to a more physiological setting,
we used organotypic rat hippocampal brain slices, which
exhibit functional local synaptic circuitry and preserved brain
architecture. Interestingly, GLT-1 transporters exhibited a
more confined mobility in slice cultures in comparison to dis-
sociated cultures. This could be due to the more compactly
packed cells and extracellular matrix, and increased number
of neuron-glial contacts or due to increased expression levels
of scaffold proteins within astrocytes in slices, which could
restrict GLT-1 mobility. Moreover, GLT-1 transporters were
more confined in astrocyte processes compared to the cell
soma in organotypic slices, possibly due to a high coverage of
synaptic sites on astrocytic processes in situ (Ventura and
Harris, 1999). Importantly, although GLT-1 was more stable
in astrocyte processes in ex vivo brain slices (compared with
dissociated culture), exogenous glutamate application or phar-
macological activation of neuronal activity nonetheless led to
a dramatic increase in GLT-1 surface diffusion, providing
compelling evidence that the activity dependent alteration of
GLT-1 mobility is an important mechanism for regulating
GLT-1 distribution in astrocytes in intact networks.
Although the transport cycle of GLT-1 is slow (12–70
ms/cycle) in comparison to the duration of glutamate in the
synaptic cleft (Bergles and Jahr, 1998; Clements et al., 1992;
Wadiche et al., 1995), efficient glutamate clearance is facili-
tated by the presence of a large number of GLT-1 transporters
on the astrocyte surface, which can also buffer glutamate by
binding it (Wadiche et al., 1995). In rat hippocampal slices,
it has been shown that perisynaptic astrocyte processes (PAPs)
are present at 62% synapse, with preference towards larger
synapses that contain post synaptic densities (Witcher et al.,
2007). PAPs express glutamate transporters (Derouiche et al.,
2012; Pannasch et al., 2014) and are highly motile processes
that are regulated by synaptically released glutamate. PAPs
selectively modify their coverage of dendritic spines around
potentiated synapses, which in turn is associated with an
increased stability of synapses (Bernardinelli et al., 2014).
While changes in surface protein levels, by processes such as
endocytosis and exocytosis will occur at longer time scale of
minutes to hours, rapid glutamate-dependent alterations in
GLT-1 surface diffusion may act as a complementary pathway
for the regulation of transporter numbers and positioning at
synapses. Our data and that of others (Murphy-Royal et al.,
2015), supports the hypothesis that rapid dispersal of
glutamate-bound GLT-1 in regions of high extracellular gluta-
mate (such as in proximity to activated synapses) could
potentially leave space for positioning of unbound GLT-1 to
allow for efficient and selective glutamate buffering. Rapid
displacement of glutamate-bound GLT-1 molecules to allow
their exchange with unbound ones, may be particularly
important in PAPs where the small size of the PAPs may limit
transporter availability in close proximity to synapses. Rapid
increases in GLT-1 surface mobility may also contribute to
limit glutamate spillover (Asztely et al., 1997) and, therefore,
prevent neuronal excitotoxicity. Our data provides further
support for the active role of astrocytes in regulating glutama-
tergic signaling and shed light on transporter surface diffusion
as an additional rapid regulatory mechanism for modulating
number of transporters at synaptic release sites to regulate
glutamate clearance in the CNS.
Acknowledgment
Grant sponsor: BBSRC (BB/I00274X/1 to J.T.K.); Grant
sponsor: Wellcome trust grants (093239/Z/10/Z and 068817/
Z/02/Z to J.T.K.); Grant sponsor: MRC Senior Non-Clinical
Fellowship (G0802377 to J.T.K.); Grant sponsor: MRC Case
PhD student (to R.N.); Grant sponsor: CoMPLEX PhD pro-
gram at UCL (to D.F.S. and J.M.).
The authors thank Dr Victoria Vaccaro for SyGCaMP5
cloning and Dr Souvik Modi for his precious advice for sin-
gle particle tracking experiments in brain slices and Dr
Ramona Eckel for her constructive comments on the
manuscript.
References
Akerboom J, Chen TW, Wardill TJ, Tian L, Marvin JS, Mutlu S, Calderon NC,
Esposti F, Borghuis BG, Sun XR, Gordus A, Orger MB, Portugues R, Engert
F, Macklin JJ, Filosa A, Aggarwal A, Kerr RA, Takagi R, Kracun S, Shigetomi
E, Khakh BS, Baier H, Lagnado L, Wang SS, Bargmann CI, Kimmel BE,
Jayaraman V, Svoboda K, Kim DS, Schreiter ER, Looger LL. 2012. Optimiza-
tion of a GCaMP calcium indicator for neural activity imaging. J Neurosci 32:
13819–13840.
Al Awabdh S, Miserey-Lenkei S, Bouceba T, Masson J, Kano F, Marinach-
Patrice C, Hamon M, Emerit MB, Darmon M. 2012. A new vesicular scaffold-
ing complex mediates the G-protein-coupled 5-HT1A receptor targeting to
neuronal dendrites. J Neurosci 32:14227–14241.
1262 Volume 64, No. 7
Arancibia-Carcamo IL, Yuen EY, Muir J, Lumb MJ, Michels G, Saliba RS,
Smart TG, Yan Z, Kittler JT, Moss SJ. 2009. Ubiquitin-dependent lysosomal
targeting of GABA(A) receptors regulates neuronal inhibition. Proc Natl Acad
Sci U S A 106:17552–17557.
Asztely F, Erdemli G, Kullmann DM. 1997. Extrasynaptic glutamate spillover
in the hippocampus: Dependence on temperature and the role of active glu-
tamate uptake. Neuron 18:281–293.
Attwell D, Barbour B, Szatkowski M. 1993. Nonvesicular release of neuro-
transmitter. Neuron 11:401–407.
Banker G, Goslin K. 1998. Culturing nerve cells, Cambridge, MA: MIT.
Bassan M, Liu H, Madsen KL, Armsen W, Zhou J, Desilva T, Chen W,
Paradise A, Brasch MA, Staudinger J, Gether U, Irwin N, Rosenberg PA.
2008. Interaction between the glutamate transporter GLT1b and the synaptic
PDZ domain protein PICK1. Eur J Neurosci 27:66–82.
Benediktsson AM, Marrs GS, Tu JC, Worley PF, Rothstein JD, Bergles DE,
Dailey ME. 2012. Neuronal activity regulates glutamate transporter dynamics
in developing astrocytes. Glia 60:175–188.
Bergles DE, Jahr CE. 1998. Glial contribution to glutamate uptake at Schaffer
collateral-commissural synapses in the hippocampus. J Neurosci 18:7709–7716.
Bernardinelli Y, Randall J, Janett E, Nikonenko I, K€onig S, Jones EV, Flores
CE, Murai KK, Bochet CG, Holtmaat A, Muller D. 2014. Activity-dependent
structural plasticity of perisynaptic astrocytic domains promotes excitatory
synapse stability. Curr Biol 24:1679–1688.
Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt
NC, Storm-Mathisen J. 1995. Glutamate transporters in glial plasma mem-
branes: Highly differentiated localizations revealed by quantitative ultrastruc-
tural immunocytochemistry. Neuron 15:711–720.
Chen W, Aoki C, Mahadomrongkul V, Gruber CE, Wang GJ, Blitzblau R, Irwin
N, Rosenberg PA. 2002. Expression of a variant form of the glutamate trans-
porter GLT1 in neuronal cultures and in neurons and astrocytes in the rat
brain. J Neurosci 22:2142–2152.
Chen W, Mahadomrongkul V, Berger UV, Bassan M, DeSilva T, Tanaka K,
Irwin N, Aoki C, Rosenberg PA. 2004. The glutamate transporter GLT1a is
expressed in excitatory axon terminals of mature hippocampal neurons.
J Neurosci 24:1136–1148.
Choquet D, Triller A. 2013. The dynamic synapse. Neuron 80:691–703.
Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL. 1992. The time
course of glutamate in the synaptic cleft. Science 258:1498–1501.
Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65:1–105.
Derouiche A, Pannicke T, Haseleu J, Blaess S, Grosche J, Reichenbach A.
2012. Beyond polarity: functional membrane domains in astrocytes and Mul-
ler cells. Neurochem Res 37:2513–2523.
Dreosti E, Odermatt B, Dorostkar MM, Lagnado L. 2009. A genetically
encoded reporter of synaptic activity in vivo. Nat Methods 6:883–889.
Eckel R, Szulc B, Walker MC, Kittler JT. 2015. Activation of calcineurin under-
lies altered trafficking of alpha2 subunit containing GABAA receptors during
prolonged epileptiform activity. Neuropharmacology 88:82–90.
Edelstein A, Amodaj N, Hoover K, Vale R, Stuurman N. 2010. Computer con-
trol of microscopes using microManager. Curr Protoc Mol Biol Chapt 14:20.
Girault JA, Barbeito L, Spampinato U, Gozlan H, Glowinski J, Besson MJ.
1986. In vivo release of endogenous amino acids from the rat striatum: Fur-
ther evidence for a role of glutamate and aspartate in corticostriatal neuro-
transmission. J Neurochem 47:98–106.
Gonzalez-Gonzalez IM, Garcia-Tardon N, Cubelos B, Gimenez C, Zafra F.
2008a. The glutamate transporter GLT1b interacts with the scaffold protein
PSD-95. J Neurochem 105:1834–1848.
Gonzalez-Gonzalez IM, Garcia-Tardon N, Gimenez C, Zafra F. 2008b. PKC-
dependent endocytosis of the GLT1 glutamate transporter depends on ubiq-
uitylation of lysines located in a C-terminal cluster. Glia 56:963–974.
Gonzalez-Gonzalez IM, Garcia-Tardon N, Gimenez C, Zafra F. 2009. Splice
variants of the glutamate transporter GLT1 form hetero-oligomers that inter-
act with PSD-95 and NMDA receptors. J Neurochem 110:264–274.
Groc L, Heine M, Cognet L, Brickley K, Stephenson FA, Lounis B, Choquet D.
2004. Differential activity-dependent regulation of the lateral mobilities of
AMPA and NMDA receptors. Nat Neurosci 7:695–696.
Haugeto O, Ullensvang K, Levy LM, Chaudhry FA, Honore T, Nielsen M,
Lehre KP, Danbolt NC. 1996. Brain glutamate transporter proteins form
homomultimers. J Biol Chem 271:27715–27722.
Holmseth S, Dehnes Y, Huang YH, Follin-Arbelet VV, Grutle NJ, Mylonakou
MN, Plachez C, Zhou Y, Furness DN, Bergles DE, Lehre KP, Danbolt NC.
2012. The density of EAAC1 (EAAT3) glutamate transporters expressed by
neurons in the mammalian CNS. J Neurosci 32:6000–6013.
Holmseth S, Scott HA, Real K, Lehre KP, Leergaard TB, Bjaalie JG, Danbolt
NC. 2009. The concentrations and distributions of three C-terminal variants
of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue
suggest differential regulation. Neuroscience 162:1055–1071.
Jackson JG, Robinson MB. 2015. Reciprocal Regulation of Mitochondrial
Dynamics and Calcium Signaling in Astrocyte Processes. J Neurosci 35:
15199–15213.
Kalandadze A, Wu Y, Robinson MB. 2002. Protein kinase C activation
decreases cell surface expression of the GLT-1 subtype of glutamate trans-
porter. Requirement of a carboxyl-terminal domain and partial dependence
on serine 486. J Biol Chem 277:45741–45750.
Kanner BI, Schuldiner S. 1987. Mechanism of transport and storage of neuro-
transmitters. CRC Crit Rev Biochem 22:1–38.
Kojima S, Nakamura T, Nidaira T, Nakamura K, Ooashi N, Ito E, Watase K,
Tanaka K, Wada K, Kudo Y, Miyakawa H. 1999. Optical detection of synapti-
cally induced glutamate transport in hippocampal slices. J Neurosci 19:2580–
2588.
Levi S, Schweizer C, Bannai H, Pascual O, Charrier C, Triller A. 2008. Homeo-
static regulation of synaptic GlyR numbers driven by lateral diffusion. Neuron
59:261–273.
Muir J, Arancibia-Carcamo IL, MacAskill AF, Smith KR, Griffin LD, Kittler JT.
2010. NMDA receptors regulate GABAA receptor lateral mobility and cluster-
ing at inhibitory synapses through serine 327 on the gamma2 subunit. Proc
Natl Acad Sci U S A 107:16679–16684.
Muir J, Kittler JT. 2014. Plasticity of GABAA receptor diffusion dynamics at
the axon initial segment. Front Cell Neurosci 8:151-
Murphy-Royal C, Dupuis JP, Varela JA, Panatier A, Pinson B, Baufreton J,
Groc L, Oliet SH. 2015. Surface diffusion of astrocytic glutamate transporters
shapes synaptic transmission. Nat Neurosci 18:219–226.
Omrani A, Melone M, Bellesi M, Safiulina V, Aida T, Tanaka K, Cherubini E,
Conti F. 2009. Up-regulation of GLT-1 severely impairs LTD at mossy fibre–
CA3 synapses. J Physiol 587:4575–4588.
Pannasch U, Freche D, Dallerac G, Ghezali G, Escartin C, Ezan P, Cohen-
Salmon M, Benchenane K, Abudara V, Dufour A, L€ubke JH, Deglon N, Knott
G, Holcman D, Rouach N. 2014. Connexin 30 sets synaptic strength by con-
trolling astroglial synapse invasion. Nat Neurosci 17:549–558.
Pathania M, Davenport EC, Muir J, Sheehan DF, Lopez-Domenech G, Kittler
JT. 2014. The autism and schizophrenia associated gene CYFIP1 is critical for
the maintenance of dendritic complexity and the stabilization of mature
spines. Transl Psychiatry 4:e374.
Peacey E, Miller CC, Dunlop J, Rattray M. 2009. The four major N- and C-
terminal splice variants of the excitatory amino acid transporter GLT-1
form cell surface homomeric and heteromeric assemblies. Mol Pharmacol 75:
1062–1073.
Petr GT, Sun Y, Frederick NM, Zhou Y, Dhamne SC, Hameed MQ, Miranda
C, Bedoya EA, Fischer KD, Armsen W, Wang J, Danbolt NC, Rotenberg A,
Aoki CJ, Rosenberg PA. 2015. Conditional deletion of the glutamate trans-
porter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy
while neuronal GLT-1 contributes significantly to glutamate uptake into syn-
aptosomes. J Neurosci 35:5187–5201.
Al Awabdh et al.: Dynamic Regulation of GLT-1 Surface Diffusion
July 2016 1263
Qu S, Kanner BI. 2008. Substrates and non-transportable analogues induce
structural rearrangements at the extracellular entrance of the glial glutamate
transporter GLT-1/EAAT2. J Biol Chem 283:26391–26400.
Rosenberg PA, Amin S, Leitner M. 1992. Glutamate uptake disguises neuro-
toxic potency of glutamate agonists in cerebral cortex in dissociated cell cul-
ture. J Neurosci 12:56–61.
Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai
Y, Hediger MA, Wang Y, Schielke JP, Welty DF. 1996. Knockout of glutamate
transporters reveals a major role for astroglial transport in excitotoxicity and
clearance of glutamate. Neuron 16:675–686.
Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L,
Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P,
Fisher PB. 2005. Beta-lactam antibiotics offer neuroprotection by increasing
glutamate transporter expression. Nature 433:73–77.
Shih J, Liu L, Mason A, Higashimori H, Donmez G. 2014. Loss of SIRT4
decreases GLT-1-dependent glutamate uptake and increases sensitivity to
kainic acid. J Neurochem 131:573–581.
Smith KR, Davenport EC, Wei J, Li X, Pathania M, Vaccaro V, Yan Z, Kittler
JT. 2014. GIT1 and betaPIX are essential for GABA(A) receptor synaptic sta-
bility and inhibitory neurotransmission. Cell Rep 9:298–310.
Smith KR, Muir J, Rao Y, Browarski M, Gruenig MC, Sheehan DF, Haucke V,
Kittler JT. 2012. Stabilization of GABA(A) receptors at endocytic zones is
mediated by an AP2 binding motif within the GABA(A) receptor beta3 subu-
nit. J Neurosci 32:2485–2498.
Sogaard R, Borre L, Braunstein TH, Madsen KL, MacAulay N. 2013. Func-
tional modulation of the glutamate transporter variant GLT1b by the PDZ
domain protein PICK1. J Biol Chem 288:20195220207.
Soni N, Reddy BV, Kumar P. 2014. GLT-1 transporter: An effective pharmaco-
logical target for various neurological disorders. Pharmacol Biochem Behav
127C:70–81.
Stephen TL, Higgs NF, Sheehan DF, Al Awabdh S, Lopez-Domenech G,
Arancibia-Carcamo IL, Kittler JT. 2015. Miro1 Regulates Activity-Driven Posi-
tioning of Mitochondria within Astrocytic Processes Apposed to Synapses to
Regulate Intracellular Calcium Signaling. J Neurosci 35:15996216011.
Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cul-
tures of nervous tissue. J Neurosci Methods 37:1732182.
Sullivan R, Rauen T, Fischer F, Wiessner M, Grewer C, Bicho A, Pow DV.
2004. Cloning, transport properties, and differential localization of two splice
variants of GLT-1 in the rat CNS: Implications for CNS glutamate homeosta-
sis. Glia 45:155–169.
Susarla BT, Robinson MB. 2008. Internalization and degradation of the gluta-
mate transporter GLT-1 in response to phorbol ester. Neurochem Int 52:709–
722.
Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K,
Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori
S, Takimoto M, Wada K. 1997. Epilepsy and exacerbation of brain injury in
mice lacking the glutamate transporter GLT-1. Science 276:1699–1702.
Thevenaz P, Ruttimann UE, Unser M. 1998. A pyramid approach to subpixel
registration based on intensity. IEEE Trans Image Process 7:27–41.
Tzingounis AV, Wadiche JI. 2007. Glutamate transporters: confining runaway
excitation by shaping synaptic transmission. Nat Rev Neurosci 8:935–947.
Ullensvang K, Lehre KP, Storm-Mathisen J, Danbolt NC. 1997. Differential
developmental expression of the two rat brain glutamate transporter proteins
GLAST and GLT. Eur J Neurosci 9:164621655.
Underhill SM, Wheeler DS, Amara SG. 2015. Differential regulation of two
isoforms of the glial glutamate transporter EAAT2 by DLG1 and CaMKII.
J Neurosci 35:5260–5270.
Ventura R, Harris KM. 1999. Three-dimensional relationships between hippo-
campal synapses and astrocytes. J Neurosci 19:6897–6906.
Wadiche JI, Arriza JL, Amara SG, Kavanaugh MP. 1995. Kinetics of a human
glutamate transporter. Neuron 14:1019–1027.
Witcher MR, Kirov SA, Harris KM. 2007. Plasticity of perisynaptic astroglia
during synaptogenesis in the mature rat hippocampus. Glia 55:13–23.
Woods G, Zito K. 2008. Preparation of gene gun bullets and biolistic trans-
fection of neurons in slice culture. J Vis Exp 12:675.
Yernool D, Boudker O, Jin Y, Gouaux E. 2004. Structure of a glutamate trans-
porter homologue from Pyrococcus horikoshii. Nature 431:811–818.
1264 Volume 64, No. 7
